Evaxion A/S

Its AI models can shorten drug development timelines and reduce the risk of failure. 

Zacks sees over 600% upside in AI-powered biotech micro cap Evaxion

Fox Corporation

Cal-Maine Foods, Inc.

Douglas Dynamics, Inc.

InvestorPlace has highlighted four stocks in its newsletter that are worth buying amid a news cycle turbocharged by U.S. President Donald Trump. The companies vary in size, but all could generate returns for investors as markets whipsaw with Trump policy pivots, the financial news and research firm argues.

InvestorPlace names four stocks to buy on ‘Trump’s turbocharged news cycle’

Byrna Technologies Inc.

Shares of less-lethal weapons manufacturer Byrna Technologies, with a market capitalization of approximately $665 million, surged nearly 10% today, Monday, February 10. The company announced that in the fiscal year 2024, which ended November 30, it recorded a net profit versus a loss in the previous year and saw its revenue double. One of the reasons for this turnaround is its successful marketing strategy, Byrna explained. To promote its products, the company collaborates with celebrities – recently, for example, it signed a contract with the daughter-in-law of U.S. President Donald Trump.

Celebrity endorsements help small-cap weapons maker Byrna turn a profit

The world’s largest cities are overcrowded, and there is <a href="https://www.worldbank.org/en/topic/urbandevelopment/overview?utm_source=in_materials">no end</a> in sight to their growth. This makes alternatives to traditional ground transportation <a href="https://www.kingsresearch.com/ru/air-taxi-market-473?utm_source=in_materials">increasingly</a> necessary. One of them is air taxis. In fact, JPMorgan <a href="https://www.cnbc.com/2023/03/01/jpmorgan-has-a-new-favorite-way-to-play-the-evtol-market.html?utm_source=in_materials">sees</a> the air taxi market reaching $1.0 trillion by 2040, versus <a href="https://www.kingsresearch.com/ru/air-taxi-market-473?utm_source=in_materials">just over</a> $3.5 billion in 2023.

The air taxi market is projected to grow to $1 trillion. What smaller companies could take off?

Shares of biotech micro cap Equillium <a href="https://www.marketwatch.com/investing/stock/eq?utm_source=in_materials">soared</a> 33% yesterday, Thursday, February 6, although some of the gains have been lost before the opening bell today. The company <a href="https://www.equilliumbio.com/investors/press-releases/news-details/2025/Equillium-Announces-Positive-Data-from-Phase-2-Study-Evaluating-Itolizumab-in-Patients-with-Moderate-to-Severe-Ulcerative-Colitis/default.aspx?utm_source=in_materials">announced</a> that its drug for ulcerative colitis, which it is testing together with Indian pharmaceutical giant Biocon, has shown results that are no worse than the standard of care for the disease. The therapy is Equillium’s lead candidate to get to market.

Announced successful drug trials boost micro cap Equillium by 33%

Quotes on the small-cap telemedicine platform Teladoc Health <a href="https://finance.yahoo.com/quote/TDOC/?utm_source=in_materials">surged</a> almost 6% yesterday, Wednesday, February 5, before extending the gains in premarket trading today. The trigger was an announcement that the company had signed an agreement to acquire Catapult Health, which provides at-home diagnostic kits. The deal follows a challenging period that saw the market valuation of Teladoc shrink more than 18-fold from its pandemic peak.

Virtual healthcare provider Teladoc to acquire competitor; shares jump 6%

Shares of Zedge, a micro-cap company that offers an emoji encyclopedia, ringtones, and wallpapers for mobile phones, surged almost 11% yesterday, Wednesday, February 5, after the company <a href="https://feeds.issuerdirect.com/news-release.html?newsid=6395584080180410&amp;utm_source=in_materials">announced</a> new restructuring steps aimed at saving up to $4 million annually.

Emoji encyclopedia creator Zedge gains amid cost reductions

Micro-cap space services provider Sidus Space <a href="https://www.marketwatch.com/investing/stock/sidu?mod=search_symbol&amp;utm_source=in_materials">soared</a> more than 10% yesterday, Tuesday, February 4, after an announcement that the company’s third satellite had arrived at a California space facility for final preparations ahead of launch. The mission will be carried out in collaboration with SpaceX, owned by Elon Musk, Sidus <a href="https://investors.sidusspace.com/news-events/press-releases/detail/220/sidus-space-announces-lizziesat-has-arrived-at?utm_source=in_materials">noted</a>.

Space-as-a-service company Sidus jumps ahead of third satellite launch

Quotes on the small-cap MAIA Biotechnology <a href="https://www.marketwatch.com/investing/stock/maia/analystestimates?mod=mw_quote_tab&amp;utm_source=in_materials">jumped</a> almost 6% yesterday, Tuesday, February 4, after the company <a href="https://ir.maiabiotech.com/news-events/press-releases/detail/124/maia-biotechnology-announces-positive-efficacy-updates-for?utm_source=in_materials">revealed</a> phase II clinical trial results for its drug that is said to offer a fundamentally new approach to cancer treatment. The therapy has proved to be superior to existing treatments, MAIA claims, and the chances of U.S. regulatory approval are "stronger than ever."

Biotech small cap MAIA jumps on positive trial data for its cancer drug

Zacks Small-Cap Research (Zacks SCR) <a href="https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_02032025_PLX_Vandermosten.pdf?utm_source=in_materials">values</a> Protalix Biotherapeutics, a small Israeli drugmaker listed in the U.S., at nearly 500% higher than its current market price. The company stands out from peers because it already generates revenue and has recently paid off its debt. This, Zacks SCR points out, takes one of the primary risks associated with small-cap stocks off the table: Smaller companies need to raise capital and dilute shareholders in the process.

Micro-cap Protalix Biotherapeutics, focused on rare diseases, has 500% upside — Zacks SCR

Shares of aerospace components manufacturer Triumph Group spiked 34% yesterday, Monday, February 3, and hit a nearly four-year high. The trigger was an announcement that the company would be <a href="https://www.triumphgroup.com/news/d8bbb1f6-86ea-4234-9d49-973f01e97979?utm_source=in_materials">acquired</a> at a 38% premium by affiliates of private equity giants Berkshire Partners and Warburg Pincus. Noble Capital Markets <a href="https://www.channelchek.com/news-channel/triumph-group-sells-for-3-billion-private-equity-giants-berkshire-partners-and-warburg-pincus-make-strategic-aerospace-bet?utm_source=in_materials#:~:text=%D0%9F%D1%80%D0%B8%D0%BE%D0%B1%D1%80%D0%B5%D1%82%D0%B5%D0%BD%D0%B8%D0%B5%20%D0%BE%D1%82%D1%80%D0%B0%D0%B6%D0%B0%D0%B5%D1%82%20%D0%BF%D1%80%D0%BE%D0%B4%D0%BE%D0%BB%D0%B6%D0%B0%D1%8E%D1%89%D1%83%D1%8E%D1%81%D1%8F%20%D0%BA%D0%BE%D0%BD%D1%81%D0%BE%D0%BB%D0%B8%D0%B4%D0%B0%D1%86%D0%B8%D1%8E%20%D0%B8%20%D1%81%D1%82%D1%80%D0%B0%D1%82%D0%B5%D0%B3%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%BE%D0%B5%20%D0%BF%D0%B5%D1%80%D0%B5%D0%BF%D0%BE%D0%B7%D0%B8%D1%86%D0%B8%D0%BE%D0%BD%D0%B8%D1%80%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5%20%D0%B2%20%D0%B0%D1%8D%D1%80%D0%BE%D0%BA%D0%BE%D1%81%D0%BC%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%BE%D0%B9%20%D0%BE%D1%82%D1%80%D0%B0%D1%81%D0%BB%D0%B8">believes</a> the deal reflects ongoing consolidation and strategic repositioning within the aerospace industry.

Aerospace supplier Triumph Group jumps on news of its being acquired 

Shares of several small-cap suppliers of avocados took a tumble yesterday, Monday, February 3, following the announcement by President Donald Trump of new tariffs on Mexico, Canada, and China. However, the losses eased later in the day after the U.S. and Mexico agreed to a truce for a month. Note that around 80% of avocados sold in the U.S. are imported from Mexico, which sparked fears of higher consumer prices.

Small caps